Glutathion reductase is an enzyme which has a similar tissue distribution to that of GPT (Manso and WrOblewsky 1958) . The determination of activity of the serum glutathione reductase (SGR.) is relatively easy to perform and can be applied to clinical cases without much hazard to patients (Horn et al. 1962 ). It was said that SGR was useful in differentiation of obstructive jaundice from paren chymatous liver diseases, and furthermore it was also suggested that this could be an important diagnostic method for the detection of metastatic liver cancer (Kerppola et al. 1959 ; West et a]. 1961; Horn et al. 1962 ). To examine these, the determination of SGR was done in patients with various diseases, mostly liver diseases, and in normal individuals.
MATERIALS AND METHODS
The determination of SGR was done strictly following the method reported by Manso and Wroblewsky (1958) . The activity determined was expressed as units/ml. The blood was taken during fasting stage from the cubital vein. The blood was divided into two parts, a part was used for the determination of SGR and the other was sent for routine liver function tests including icterus index, serum transaminases (GOT and GPT), alkaline phosphatase, thymol turbidity test, and zinc sulfate turbidity test. The methods for these hepatic tests were previously reported from this department (Saito et al. 1963) .
The patients subjected to this investigation included 110 patients with acute hepatitis, 117 patients with chronic hepatitis, 47 patients with liver cirrhosis, 9 patients with obstructive jaundice due to either benign or malignant causes, 30 patients with malignant neoplastic diseases, and 13 patients with liver cancer which included 8 metastatic and 5 primary hepatic cancer. As the control group, 42 apparently healthy persons, most of them were blood donors for the blood bank, were subjected to the examination.
In all of these patients with hepatic diseases, the diagnosis were based on histological examination. The presence of the metastasis, in patients with malignant neoplasm, was either ruled in or out by the peritoneoscopic examination, surgery, or necropsy.
RESULTS
In 42 normal persons, SGR was found to be 24.1+5.8 units/ml (mean±s.D.). This group was composed of 18 males and 24 females. Ages ranged from 20 to 64 years. There were no significant age or sex differences noted .
In acute hepatitis, SGR was found to be 77.1±27.6 units/ml (mean±S .n.). This is significantly elevated above the control level at the 1% level of significance (t-test). The finding of high value of SGR in patients with acute hepatitis was initially reported by Manso & Wroblewsky (1958) and supported by Kerppola et al. (1959) . However, West et al. (1961) found the incidence and degree of the elevation of SGR in patients with hepatitis not to be impressive.
The opinions on the clinical significance of SGR in hepatitis thus differ. Kerppola et al. (1959) stated that the high values were found in the phase of increasing jaundice but they became rapidly normal within a week after the peak of the icterus had been attained. West et al. (1961) also stated that SGR levels were usually elevated in the first week of illness. Differences of a few weeks in the clinical course will therefore introduce significant differences of SGR activity. To investigate this point, SGR activities in 55 patients with acute hepatitis were plotted against time scale to show when the determination was done and how high the SGR was (Fig. 1) . At the initial phase of acute hepatitis, SGR was found to be abnormally elevated in all patients, and the incidence and the degree of elevation showed gradual decreases with time showing 85.7% to be abnormal in 2 to 3 weeks after the onset and 50% to be abnormal in the period of 21 to 24 days after the onset. It is therefore very important to know when or in which phase of acute hepatitis the determination of SGR was done. It is also interesting that there is a significant difference of SGR between acute hepatitis and chronic hepatitis . Inclusion of both acute and chronic hepatitis in the category of hepatitis and There were 55 such patients. discussing the meaning of SGR determination will confuse the issue. West et al. (1961) pointed out that, in several patients with hepatitis, normal or only a slightly elevated SGR was found when transaminases were highly elevated. In the present investigation, although one patient showed only a moderate elevation of SGR when SGPT showed a value of 1250 units, statistical evaluation revealed the presence of significant correlation between SGR and SGPT or SGOT in patients with acute hepatitis. Such a correlation was not found in patients with chronic hepatitis. Kerppola et al. (1959) found the elevation of SGR before the time when icterus reached the peak in patients with acute hepatitis. In our experience, there were patients with acute hepatitis without overt jaundice who showed identical pattern or rise and decrease of SGR as seen in patients with overt icterus. Thus, the rapid increase of SGR at the initial phase and rapid decrease after the attainment of the peak of icterus is not related to the changes in serum bilirubin level. Previously we have observed (Kumata et al. 1975 ) that in -CC14liver damaged rat SGR increased earlier than transaminases and decreased much faster than transaminases. The same pattern of changes was found in the clinical situation in patients with acute hepatitis. In malignant neoplastic group, SGR was found to be elevated. This confirms the reports of other authors (Manso and Wroblewsky 1958; Kerppola et al. 1959; West et al. 1961; Horn et al. 1962 ). The elevated SGR found in malignant neoplastic diseases was, however, not found among the patients with cancer of the stomach. West et al. (1961) and Horn et al. (1962) were in opinion that the metastasis to the liver is a factor to cause the elevation of SGR. In the present investigation, SGR was found to be significantly elevated in patients with liver cancer than in patients with gastric cancer (p<0.05). However, not all of the patients with metastatic liver cancer showed elevated SGR. There were 8 patients with metastatic liver cancer and 3 showed elevated SGR . It is, however, interesting to note that in these 3 patients, SGR was very highly elevated with the value of 336, 264, and 128 units, respectively. Thus, it is true that some patients with cancer metastasis to the liver show highly elevated SGR but the presence of the metastasis do not always cause elevation of SGR. Even in 5 patients with primary liver cancer 3 showed normal values. It is also interesting to note that all 4 patients with cancer of the pancreas and 3 patients with choled ochus cancer showed elevated SGR, and this elevation was invariably associated with the elevated alkaline phosphatase. This association of the elevated SGR and alkaline phosphatase, however, was not observed in patients with liver cancer and therefore the elevated SGR in patients with malignant neoplastic diseases can not be due to the same mechanism of the elevated alkaline phosphatase. Kerppola et al. (1959) found no elevation of SGR in all of the patients with obstructive or non-obstructive cholelithiasis and acute and chronic cholecystitis. They also pointed out that in the presence of obstructive jaundice, increased SGR points to malignant diseases. West et al. (1961) found that only 8 of 26 patients with extrahepatic biliary tract diseases had elevated SGR even though the majority of patients had elevated transaminases and were jaundiced. In the present investigation, all of 9 patients with obstructive jaundice showed elevated SGR level. However, the degree of elevation was different between patients with benign obstruction and malignant jaundice. None of patients with benign obstruction showed values of more than 100 units and all of the patients with malignant obstruction showed values of more than 120 units. Thus the results of the present investigation confirmed a part of the statements made by Kerppola et al. (1959) .
Thus, although the determination of SGR is easy to perform and can be applied as routine examination as pointed out by Horn et al. (1962) , its clinical significance seems to be limited. The rapid decrease of SGR level from the initial high level in the course of parenchymatous liver disease suggests the acute hepatitis, and high value of SGR in obstructive jaundice suggests the malignant cause.
